The Metabolic Syndrome in Australia: Prevalence using four definitions

Diabetes Research and Clinical Practice

Volumn 77, Issue 3, 2007, Pages 471-478

  Cameron, Adrian J ^a   Magliano, Dianna J ^a   Zimmet, Paul Z ^a   Welborn, Tim ^b   Shaw, Jonathan E ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

AusDiab; Australia; Cardiovascular disease risk; Central obesity; Insulin resistance; Metabolic Syndrome

Indexed keywords

ALBUMIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; ATTRIBUTABLE RISK; AUSTRALIA; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DIABETES MELLITUS; DYSLIPIDEMIA; FEMALE; HEALTH SURVEY; HIGH RISK POPULATION; HUMAN; HYPERINSULINEMIA; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MICROALBUMINURIA; OBESITY; ORAL GLUCOSE TOLERANCE TEST; POPULATION RISK; PREVALENCE; RADIOIMMUNOASSAY; SEX DIFFERENCE; SYNDROME DELINEATION; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

ANTHROPOMETRY; AUSTRALIA; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CLASSIFICATION; FASTING; HUMANS; INSULIN RESISTANCE; METABOLIC SYNDROME X; PREVALENCE; RISK;

EID: 34547687928     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2007.02.002     Document Type: Article

References (21)

1. Cameron A.J., Welborn T.A., Zimmet P.Z., Dunstan D.W., Owen N., Salmon J., et al. Overweight and obesity in Australia: the 1999-2000 Australian Diabetes, Obesity and Lifestyle Study (AusDiab). MJA 178 (2003) 427-432
2. Dunstan D.W., Zimmet P.Z., Welborn T.A., de Courten M.P., Cameron A.J., Sicree R.A., et al. The rising prevalence of diabetes and impaired glucose tolerance: the Australian Diabetes, Obesity and Lifestyle Study. Diabetes Care 25 (2002) 829-834
3. Reaven G. Metabolic syndrome: pathophysiology and implications for management of cardiovascular disease. Circulation 106 (2002) 286-288
4. Carr D.B., Utzschneider K.M., Hull R.L., Kodama K., Retzlaff B.M., Brunzell J.D., et al. Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome. Diabetes 53 (2004) 2087-2094
5. Ford E.S. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care 28 (2005) 1769-1778
6. World Health Organization. Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications; Part 1: Diagnosis and Classification of Diabetes Mellitus (1999), Department of Noncommunicable Disease Surveillance, Geneva
7. Balkau B., and Charles M.A. Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diab. Med. 16 (1999) 442-443
8. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III), JAMA 285 (2001) 2486-2497.
9. Alberti K.G., Zimmet P., and Shaw J. The metabolic syndrome-a new worldwide definition. Lancet 366 (2005) 1059-1062
10. Dunstan D.W., Zimmet P.Z., Welborn T.A., Cameron A.J., Shaw J., de Courten M., et al. The Australian Diabetes, Obesity and Lifestyle Study (AusDiab)-methods and response rates. Diab. Res. Clin. Pract. 57 (2002) 119-129
11. Briganti E.M., Shaw J.E., Chadban S.J., Zimmet P.Z., Welborn T.A., McNeil J.J., et al. Untreated hypertension among Australian adults: the 1999-2000 Australian Diabetes, Obesity and Lifestyle Study (AusDiab). MJA 179 (2003) 135-139
12. Levy J., Matthews D., and Hermans M. Correct homeostatic model assessment (HOMA) evaluation uses the computer program. Diabetes Care 21 (1998) 2191-2192
13. Anderson K., Odell P., Wilson P., and Kannel W. Cardiovascular disease risk profiles. AMJ 121 (1991) 293-298
14. Australian Bureau of Statistics. Population by Age and Sex, Australian States and Territories (1999), Australian Bureau of Statistics, Canberra
15. Genuth S. Lowering the criterion for impaired fasting glucose is in order. Diabetes Care 26 (2003) 3331-3332
16. Ford E.S. Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the US. Diabetes Care 28 (2005) 2745-2749
17. Borch-Johnsen K., Colagiuri S., Balkau B., Glumer C., Carstensen B., Ramachandran A., et al. Creating a pandemic of prediabetes: the proposed new diagnostic criteria for impaired fasting glycaemia. Diabetologia 47 (2004) 1396-1402
18. Ford E.S., Abbasi F., and Reaven G.M. Prevalence of insulin resistance and the metabolic syndrome with alternative definitions of impaired fasting glucose. Atherosclerosis 181 (2005) 143-148
19. Kahn R., Buse J., Ferrannini E., and Stern M. The Metabolic Syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 28 (2005) 2289-2304
20. Meigs J.B., Wilson P.W., Nathan D.M., D'Agostino Sr. R.B., Williams K., and Haffner S.M. Prevalence and characteristics of the metabolic syndrome in the San Antonio Heart and Framingham Offspring Studies. Diabetes 52 (2003) 2160-2167
21. Athyros V.G., Ganotakis E.S., Elisaf M., and Mikhailidis D.P. The prevalence of the metabolic syndrome using the National Cholesterol Educational Program and International Diabetes Federation definitions. Curr. Med. Res. Opin. 21 (2005) 1157-1159